SCHEMBL31691397

SCHEMBL31691397

COC(=O)c1ccc(Cc2ccccn2)c(C)n1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MRGPRX4 Q96LA9 1/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ MAPT P10636 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ PTGER4 P35408 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ GRM5 P41594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31691466 0.85 LMNA (0.45) MRGPRX4KDM4EALDH1A1MAPTLMNA
SCHEMBL9089861 0.77 MAPK1 (0.44) KDM4EHSD17B10ALDH1A1MAPTLMNA
SCHEMBL31691426 0.76 ALOX15 (0.47) KDM4EHSD17B10ALDH1A1ALOX15MAPT
SCHEMBL19474955 0.76 ALDH1A1 (0.56) KDM4EHSD17B10ALDH1A1ALOX15LMNA
SCHEMBL16682715 0.74 MAPT (0.43) MRGPRX4KDM4EHSD17B10ALDH1A1MAPT
SCHEMBL31691389 0.73 KMT2A (0.47) KDM4EALDH1A1ALOX15MAPTHPGD
SCHEMBL23422973 0.71 MAPT (0.40) MRGPRX4KDM4EHSD17B10ALDH1A1MAPT
SCHEMBL7834117 0.71 PKM (0.60) KDM4EHSD17B10ALDH1A1ALOX15MAPT
SCHEMBL31172637 0.70 KLKB1 (0.46) KDM4EHSD17B10ALDH1A1ALOX15MAPT
SCHEMBL29576494 0.69 KDM4E (0.68) KDM4EALDH1A1MAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250304535-A1 KAT6 Inhibitors BEIGENE SWITZERLAND GMBH (CH) 2025-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250304535-A1 KAT6 Inhibitors KAT6A, KAT6B, KAT2A MRGPRX4 3707/4885KDM4E 349/4885HSD17B10 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback